Kaya Holdings (KAYS) EBITDA Margin Growth (3y) (2017 - 2025)
Kaya Holdings (KAYS) EBITDA Margin Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1,673.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -37.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,442.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 11,299.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3,972.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5,310.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -15,676.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1,106.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2,466.00 |
| 10 | Kaya Holdings | - | - | 5,370.00 | -481,828.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -481,828.00 |
| Jun 30, 2025 | -147,214.00 |
| Mar 31, 2025 | -421,501.00 |
| Dec 31, 2024 | 186,262.00 |
| Sep 30, 2024 | -3.45 Mn |
| Mar 31, 2024 | -72,718.00 |
| Dec 31, 2023 | -10,025.00 |
| Sep 30, 2023 | -18,816.00 |
| Jun 30, 2023 | -47,059.00 |
| Mar 31, 2023 | -55,590.00 |
| Dec 31, 2022 | -21,518.00 |
| Sep 30, 2022 | 604.00 |
| Jun 30, 2022 | -950.00 |
| Mar 31, 2022 | -5,413.00 |
| Dec 31, 2021 | -1,208.00 |
| Sep 30, 2021 | 2,912.00 |
| Jun 30, 2021 | -2,372.00 |
| Mar 31, 2021 | 39,551.00 |
| Dec 31, 2020 | 2,597.00 |
| Sep 30, 2020 | -13,404.00 |